Impact of Peritoneal Dialysis Solutions on Peritoneal Immune Defense

Gallimore B. , Gagnon R.F. , Stevenson M.M. Cytotoxicity of commercial peritoneal dialysis solutions towards peritoneal cells of chronically uremic mice. Nephron 1986; 43: 283–9.

Rubin J. , Lin L.M. , Lewis R. , Cruse J. , Bower J.D. Host defense mechanisms in continuous ambulatory peritoneal dialysis. Clin Nephrol 1983; 20: 140–4.

Van Bronswijk H. , Verbrugh H.A. , Bos H.J. Cytotoxic effects of commercial continuous ambulatory peritoneal dialysis (CAPD) fluids and of bacterial exoproducts on human mesothelial cells in vitro. Perit Dial Int 1989; 9: 197–202.

Alobaidi H.M. , Coles G.A. , Davies M. , Lloyd G. Host defense in continuous ambulatory peritoneal dialysis: The effect of the dialysate on phagocyte function. Nephrol DialTransplant 1986; 1: 16–21.

Duwe A.K. , Vas S.I. , Weatherhead J.W. Effects of the composition of peritoneal dialysis fluid on chemoluminescence, phagocytosis, and bactericidal activity in vitro. Infect Immun 1981; 33: 130–5.

Topley N. , Alobaidi H.M. , Davies M. , Coles G.A. , Williams J.D. , Lloyd D. The effect of dialysate on peritoneal phagocyte oxidative metabolism. Kidney Int 1988; 34: 404–11.

Ing B.L. , Gupta D.K. , Nawab Z.M. , Zhou F.Q. , Rahman M.A. , Daugirdas J.T. Suppression of neutrophil superoxide production by conventional peritoneal dialysis solutions. Int J ArtifOrgans 1988; 11: 351–4.

Samuelsson B. Leukotrienes: Mediators of immediate hypersensitivity reactions and inflammation. Science 1983; 220: 568–76.

Bray M.A. The pharmacology and pathophysiology of leukotriene B4. Br Med Bull 1983; 39: 249–54.

Jörres A. , Jörres D. , Topley N. , Gahl G.M. , Mahiout A. Leukotriene release from peripheral and peritoneal leukocytes following exposure to peritoneal dialysis solutions. Nephrol Dial Transplant 1991; 6: 495–501.

Jörres A. , Jörres D. , Gahl G.M. , Schulz E. , Mahiout A. Peritoneal dialysate inhibits leukotriene release from peripheral and peritoneal polymorphonuclear leuko cytes (PMN) (Abstract). VIIIth world congress of the International Society for Artificial Organs, Montreal, 1991.

Jäättela M. Biologic activities and mechanism of action of tumor necrosis factor alpha/cachectin. Lab Invest 1991; 64: 724–42.

Beutler B. , Cerami A. Chachektin: More than a tumor necrosis factor. N Engl J Med 1987; 311: 1316–24.

Elias J.A. , Gustilo K. , Baeder W. , Freundlich B. Synergistic stimulation of fibroblast prostaglandin production by recombinant interleukin-l and tumor necrosis factor. J Immunol 1987; 138: 3812–6.

Topley N. , Brown Z. , Jörres A. Human peritoneal mesothelial cells (HPMC) synthesise interleukin-8: Synergistic induction by interleukin-lβ (lL-lβ) and tumor necrosis factor α (TNFα). Am J Pathol 1993; 142: 1–11.

Topley N. , Jörres A. , Luttmann W. Human peritoneal mesothelial cells synthesize interleukin-6: Induction by IL-lβ and TNFα. Kidney Int 1993; 43: 226–233.

Matsushima K. , Oppenheim J.J. Interleukin-8 and MCTAF: Novel inflammatory cytokines inducible by IL-l and TNF. Cytokine 1989; 1: 2–13.

Kishimoto T. The biology of interleukin-6. Blood 1989; 74: 1–10.

Schindler R. , Mancilla J. , Endres S. , Ghorbani R. , Clark S.C. , Dinarello C.A. Correlations in the production of interleukin-6, IL-l and TNFα in human blood mononuclear cells: IL-6 suppresses IL-l and TNFα. Blood 1990; 75: 40–7.

Jörres A. , Jörres D. , Gahl G.M. Leukotriene B4 and tumor necrosis factor release from leukocytes: Effect on peritoneal dialysate. Nephron 1991; 58: 276–82.

Jörres A. , Topley N. , Steenweg L. , Muller C. , Kottgen E. , Gahl G.M. Inhibition of cytokine synthesis by peritoneal dialysate persists throughout the CAPD cycle. Am J Nephrol 1992; 12: 80–5.

Jörres A. , Topley N. , Scholz P. , Ludat K. , Muller C. , Gahl G.M. CAPD and cytokines: peritoneal dialysate inhibits the production of IL-8, IL-6 and TNFα (Abstract). 25th annual meeting of the American Society of Nephrology, Baltimore, 1992.

Liberek T. , Topley N. , Jörres A. Peritoneal dialysis fluid inhibition of neutrophil (PMN) respiratory burst activation is related to the lowering of intracellular pH [pH]i. Nephron (in press).

Liberek T. , Topley N. , Jörres A. , Coles G.A. , Gahl G.M. , Williams J.D. Peritoneal dialysis fluid (PDF) inhibition of phagocyte function: Effects of osmolality and glucose concentration. J Am Soc Nephrol 1993; 3: 1508–15.